It has been demonstrated that residual normal long-term clonogenic CD34+CD38− are detectable in CML patients at diagnosis, and that the proportion of LSCs varies greatly across different patients. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.